Access cutting-edge long covid treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access long covid specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related long covid treatment provided free
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things ("brain fog") and fatigue. Researchers will compare NE3107 to a placebo (a look-alike substance that contains no drug) to see if NE3107 works to treat neurocognitive and fatigue symptoms of long COVID. Participants wil
Sponsor: BioVie Inc.
Check if you qualify for this long covid clinical trial in Chicago, IL
If you're searching for long covid treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced long covid specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.